Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: Summary statement of a First National Institutes of Health/Office of Rare Diseases conference

National Human Genome Research Institute, the Molecular Imaging Program, National Cancer Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, Pediatric Nephrology, Children’s Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, WI, Internal Medicine, Nephrology, Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, Pediatric Nephrology, Children’s Hospital at Montefiore, Albert Einstein College of Medicine, New York, NY, Internal Medicine, Nephrology, Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Pediatric Nephrology, University of Alabama at Birmingham, Birmingham, AL, Internal Medicine, Nephrology and Gastroenterology, Mayo Clinic, Rochester, MN, Pediatric Nephrology, MassGeneral Hospital for Children at Massachusetts General Hospital, Harvard Medical School and the Autosomal Recessive Polycystic Kidney Disease/Congenital Hepatic Fibrosis Alliance and the Department of Internal Medicine, Harvard Institutes of Medicine, Boston, MA, Pediatric Gastroenterology, Children’s National Medical Center, The George Washington University, Washington, DC, the Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, the Departments of Pediatric Hepatology and Internal Medicine, Nephrology, Mount Sinai School of Medicine, The Mount Sinai Hospital, NY.